Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 6.61% | -57.69% | 191.84% | 94.06% |
| Total Receivables | -- | -- | -38.47% | -19.17% | 69.01% |
| Inventory | -- | -- | 10.90% | -10.93% | -12.87% |
| Prepaid Expenses | -- | -- | 7.44% | -40.30% | -22.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -96.84% | -9.46% | -11.68% | 5.43% |
|
|
|||||
| Total Current Assets | -- | -96.84% | -9.46% | -11.68% | 5.43% |
| Net Property, Plant & Equipment | -- | -- | -4.24% | 90.19% | 14.74% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -100.00% | -16.59% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -4.10% | -77.96% | -4.95% | 21.76% | 6.12% |
|
|
|||||
| Total Accounts Payable | -66.85% | -56.10% | -2.34% | 25.67% | 6.01% |
| Total Accrued Expenses | -- | -- | 0.57% | 5.42% | -40.80% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 8.53% | -8.44% | 1.11% |
| Total Finance Division Other Current Liabilities | -- | -- | 11.67% | -68.75% | 44.60% |
| Total Other Current Liabilities | -- | -- | 11.67% | -68.75% | 44.60% |
| Total Current Liabilities | -66.85% | -80.91% | 2.06% | -2.70% | -6.11% |
|
|
|||||
| Total Current Liabilities | -66.85% | -80.91% | 2.06% | -2.70% | -6.11% |
| Long-Term Debt | -- | -- | -2.83% | 0.35% | 86.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -5.91% | 154.58% | 84.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -77.28% | -76.67% | 1.27% | 1.23% | -2.80% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 6.41% | 7.59% |
| Retained Earnings | 13.41% | 30.53% | -1.50% | -1.35% | -1.84% |
| Treasury Stock & Other | 0.00% | -95.57% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 106.32% | 76.11% | -4.21% | 6.22% | 5.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 106.32% | 76.11% | -4.21% | 6.22% | 5.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 106.32% | 76.11% | -4.21% | 6.22% | 5.68% |
|
|
|||||